Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale EVP, Operations sold 54,792 shares at $379.12 ($20,772,595)
  2. 4 Open-market sale VP, Finance & CAO sold 1,000 shares at $375.79 ($375,790)
  3. 4 Shares withheld for taxes EVP, Research and Development gave up 3,104 shares (to pay taxes)
  4. 4 Open-market sale SVP & CCO sold 3,139 shares at $337.26 ($1,058,667)
  5. 4 Open-market sale SVP, Business Development sold 890 shares at $336.24 ($299,256)
  6. 4 Open-market sale EVP, Global Commercial Ops sold 6,879 shares at $336.83 ($2,317,071)
  7. 4 Gift EVP & Chief Technology Officer gave 6,799 shares (gift)
  8. 4 Grant or award Director acquired 218.61 shares (grant or award)
  9. 4 Grant or award Director acquired 265.46 shares (grant or award)
  10. 4 Grant or award Director acquired 218.61 shares (grant or award)
  11. 4 Shares withheld for taxes SVP, Business Development gave up 226 shares (to pay taxes)
  12. 4 Shares withheld for taxes VP, Finance & CAO gave up 202 shares (to pay taxes)
  13. 4 Open-market sale SVP & CCO sold 1,267 shares at $296.99 ($376,280)
  14. 4 Grant or award Director acquired 121.43 shares (grant or award)
  15. 4 Grant or award Director acquired 147.45 shares (grant or award)
  16. 4 Grant or award Director acquired 121.43 shares (grant or award)
  17. 4 Open-market sale SVP, Business Development sold 1,500 shares at $289.68 ($434,520)
  18. 4 Grant or award Director acquired 809 shares (grant or award)
  19. 4 Grant or award Director acquired 809 shares (grant or award)
  20. 4 Grant or award Director acquired 809 shares (grant or award)

Page 5 of 99 · 1,961 filings